Enrico Garanzini

Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant

Alessandro Cucchetti, Matteo Serenari, Carlo Sposito et al. · Journal of Hepatology · 2020 · 79 citations · Full text

Metroticket 2.0, Hepatology, Hepatocellular Carcinoma +14

Treatment of collecting duct carcinoma: current status and future perspectives.

Giuseppe Procopio, Isabella Testa, Roberto Iacovelli et al. · PubMed · 2014 · 33 citations

Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms

Anna Maria Ierardi, Mario Petrillo, Enrico Maria Fumarola et al. · Minimally Invasive Therapy & Allied Technologies · 2019 · 17 citations

Sarcoidosis-like disease mimicking metastases during adjuvant ipilimumab therapy in advanced melanoma patient: CT scan and MRI help in managing difficult clinical decision

Enrico Garanzini, Davide Scaramuzza, Gaia Spadarella et al. · BJR|case reports · 2020 · 12 citations · Full text

Advanced Cutaneous Melanoma, Immunology, Pathology +18

Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases.

Giuseppe Procopio, Elena Verzoni, Pamela Biondani et al. · PubMed · 2014 · 10 citations